Arkolith/Insider Trading/IBRX/Form 4

Selecky Christobel

DirectorImmunityBio, Inc. (IBRX) · full profile →Form 4 · filed Jul 7, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.4M
Net Open-Market Flow
-$1.4M
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 1, 2026Option exercise(M)35K$2.98$104K35K
Jul 1, 2026Option exercise(M)124K$2.99$372K159K
Jul 1, 2026Sell(S)159K$9.02$1.4M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 1, 2026Option exercise(M)35K—$00
Jul 1, 2026Option exercise(M)124K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001849739-26-000014) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML